Valence Life Sciences
North America, New York, United States, New York
Description
Valence Life Sciences is the only life sciences venture firm with a proven track record of success in late-stage investing.
Investor Profile
Valence Life Sciences has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 3 rounds, about 38% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Private Equity, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical Device, Biotechnology.
Stage Focus
- Series Unknown (25%)
- Private Equity (25%)
- Series D (25%)
- Series C (13%)
- Series E (13%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical Device
- Biotechnology
- Information Technology
- Life Science
- Manufacturing
- Biopharma
- Health Diagnostics
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Valence Life Sciences frequently co-invest with?
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
What are some of recent deals done by Valence Life Sciences?
Find More Investors Like Valence Life Sciences
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
